MECAS Accelerates U.S. Respiratory Therapy Market Entry with Exclusive Distribution Deal with Top-Tier Partner
Global critical care solutions company MECAS is accelerating its entry into the U.S. respiratory therapy equipment market.
On March 30, MECAS announced that it had signed an exclusive distribution agreement for North America with a top-tier partner that operates a nationwide healthcare distribution network in the United States for its high-flow respiratory therapy system, the "HFT750U (OmniOx Series)."
This agreement is seen as a strategic move in response to the growth potential of the U.S. high-flow nasal cannula (HFNC) equipment market. According to industry sources, the size of the U.S. HFNC equipment market is expected to reach approximately USD 3.6 billion (about KRW 4.8 trillion) by 2026.
In particular, MECAS secured exclusive supply rights after obtaining FDA 510(k) clearance, earning recognition for the product's clinical efficacy from its partner, which has access to major hospital networks in all 50 states. Through this, the company has established a stable supply base in the rapidly growing non-invasive respiratory therapy device market.
This agreement is regarded as the partnership with the broadest distribution network since the launch of the OmniOx Series. The fact that a top-tier player in the U.S. medical device market has highly valued the technological competitiveness of the HFT750U is expected to serve as a significant turning point for entry into the premium North American market.
The HFT750U is praised for its safety, versatility, and mobility. It meets the latest FDA biocompatibility standards (ISO 18562), ensuring the safety of medical gases delivered to patients, and integrates HFNC, CPAP, and Bi-Level functions into a single device to improve operational efficiency. In addition, it is equipped with a built-in battery, allowing continuous treatment even during patient transfers within hospitals.
While the company did not disclose specific contract terms, it explained that this collaboration is expected to lead to a shift towards a high value-added sales structure. Furthermore, it expects that expanding equipment supply will increase brand trust and strengthen the foundation for mid- to long-term growth.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
A MECAS official stated, "The U.S. HFNC equipment market, estimated at about KRW 4.8 trillion, has high entry barriers, but it is a market where significant value can be generated once established. Together with a partner that has strong execution capabilities across North America, we intend to set a new global standard for non-invasive respiratory therapy."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.